BME Seminar
"Mitochondrial morphology changes in postischemic endothelial cells: A bioengineering perspective" by B. Rita Alevriadou, PhD
-
Room 145 Mount Hall
1050 Carmack Road
Columbus, OH 43210
United States
Biomedical Engineering Seminar
Tuesday 11/9/2010, 4-5PM
Mount Hall (West Campus), Room 145
"Mitochondrial morphology changes in postischemic endothelial cells:
A bioengineering perspective"
by
B. Rita Alevriadou, PhD
Associate Professor, Departments of Biomedical Engineering and Internal Medicine (Cardiology), OSU
Abstract:
Our goal is to delineate the role of mechanical forces and oxidative stress in endothelial cell (EC) intracellular signaling and gene expression. Our group discovered that cultured EC exposure to fluid shear stress reproduces certain aspects of the reperfusion (RP)-induced endothelial injury, namely the nitric oxide (NO)/peroxynitrite-mediated inhibition of respiration and mitochondrial production of reactive oxygen species (ROS). Current work concentrates on the mitochondrial changes during hypoxia/reoxygenation (H/RO) or simulated ischemia/reperfusion (I/RP), in order to better understand the mechanisms that lead to the EC dysfunction following I/RP of the heart. Following treatment, cultured ECs are stained with mitotracker and digital fluorescent images are obtained. Morphological parameters are determined and used for quantitative comparisons of the mitochondrial network between treatments. We found that both H/RO- and I/RP-exposed ECs undergo changes in mitochondrial morphology, and ROS and NO are responsible for the I/RP-induced increase in mitochondrial fission. Since mitochondrial fission has been implicated in the induction of cell apoptosis, our studies suggest that, by controlling mitochondrial network morphology, we may be able to lessen the EC injury following cardiac I/RP.
Biographical Information: B. Rita Alevriadou
Dr. Alevriadou received her PhD in Chemical Engineering, Bioengineering & Biosciences Institute, from Rice University in Houston, TX in 1992. Following postdoctoral training in the Department of Molecular & Experimental Medicine of the Scripps Research Institute, La Jolla, CA, she joined the BME Department of the Johns Hopkins University, Baltimore, MD, as an Assistant Professor. In 2003, she joined the BME Center (now Department) and the Davis Heart & Lung Research Institute at OSU, as an Associate Professor of BME & Internal Medicine (Cardiology). She is a member of the Integrated Biomedical Science and Biophysics Graduate Programs and the Institute of Mitochondrial Biology. Dr. Alevriadou is a member of BMES, is on the editorial board of the American Journal of Physiology-Cell, and regularly serves as a reviewer for funding agencies and journals related to the bioengineering aspects of vascular biology.